Growth, weight gain and BMI in virally suppressed children on antiretroviral therapy with specific reference to dolutegravir

[1]  M. Yotebieng,et al.  Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis , 2022, Journal of the International AIDS Society.

[2]  C. Giaquinto,et al.  Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. , 2021, The New England journal of medicine.

[3]  A. Mocroft,et al.  Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium. , 2021, The lancet. HIV.

[4]  C. Ohlsson,et al.  Prevalence of overweight and obesity from 5 to 19 years of age in Gothenburg, Sweden , 2021, Acta paediatrica.

[5]  H. Masur,et al.  Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort , 2021, Open forum infectious diseases.

[6]  K. Mounzer,et al.  Weight gain before and after switch from TDF to TAF in a U.S. cohort study , 2021, Journal of the International AIDS Society.

[7]  H. Kirchner,et al.  Transition to Dolutegravir Is Associated With an Increase in the Rate of Body Mass Index Change in a Cohort of Virally Suppressed Adolescents , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  G. Maartens,et al.  CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Toni,et al.  Auxological and endocrinological features in internationally adopted children , 2020, Italian Journal of Pediatrics.

[10]  J. Li,et al.  Excessive Weight Gain Associated With Dolutegravir Initiation in a 10-Year-Old Female With Perinatally Acquired Human Immunodeficiency Virus: A Case Report and Review of the Literature. , 2020, Journal of the Pediatric Infectious Diseases Society.

[11]  J. Albert,et al.  Antiretroviral treatment for HIV infection: Swedish recommendations 2019 , 2020, Infectious diseases.

[12]  G. McComsey,et al.  Weight gain and integrase inhibitors. , 2019, Current opinion in infectious diseases.

[13]  H. Stellbrink,et al.  Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Giaquinto,et al.  Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand , 2019, AIDS.

[15]  T. Sterling,et al.  Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Golsäter,et al.  Trends in prevalence of thinness, overweight and obesity among Swedish children and adolescents between 2004 and 2015 , 2018, Acta paediatrica.

[17]  Paige L. Williams,et al.  Growth and pubertal development in HIV-infected adolescents , 2018, Current opinion in HIV and AIDS.

[18]  J. Albert,et al.  Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden , 2018, AIDS.

[19]  Gretchen A. Stevens,et al.  Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.

[20]  L. Dimeglio,et al.  Delay in sexual maturation in perinatally HIV-infected youths is mediated by poor growth , 2017, AIDS.

[21]  D. Raben,et al.  Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. , 2016, International journal of epidemiology.

[22]  B. Richardson,et al.  Growth reconstitution following antiretroviral therapy and nutritional supplementation: systematic review and meta-analysis , 2015, AIDS.

[23]  T. Eboua,et al.  Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort , 2015, The Pediatric infectious disease journal.

[24]  J. Breda,et al.  WHO European Childhood Obesity Surveillance Initiative 2008: weight, height and body mass index in 6–9‐year‐old children , 2013, Pediatric obesity.

[25]  T. Cole,et al.  Extended international (IOTF) body mass index cut‐offs for thinness, overweight and obesity , 2012, Pediatric obesity.

[26]  L. Proos.  Growth & development of Indian children adopted in Sweden. , 2009, The Indian journal of medical research.

[27]  C. Nishida,et al.  Development of a WHO growth reference for school-aged children and adolescents. , 2007, Bulletin of the World Health Organization.

[28]  J. Albert,et al.  Antiretroviral treatment of HIV infection: Swedish recommendations 2007 , 2007, Scandinavian journal of infectious diseases.

[29]  Mercedes Onis,et al.  WHO Child Growth Standards based on length/height, weight and age , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[30]  A. Blaxhult,et al.  Antiretroviral treatment of HIV infection: Swedish recommendations 2005 , 2006, Scandinavian journal of infectious diseases.

[31]  S. Arpadi.  Growth Failure in Children With HIV Infection , 2000, Journal of acquired immune deficiency syndromes.

[32]  K. Pasi,et al.  Growth in haemophilic boys after HIV infection. , 1990, Archives of disease in childhood.

[33]  K. Shannon,et al.  Acquired immune deficiency syndrome in childhood. , 1985, The Journal of pediatrics.